In turn, HTHQ administration to PD animals resulted in a decrease in the severity of inflammatory processes, as evidenced by a decrease in MPO activity, serum IgG level, expression of p65 NF-κB, and mRNA content of proinflammatory genes in the rat brain. The gene discussed is MPO; the disease is Parkinson disease.